Evolution of Biocatalysis at Novartis over the last 40 Years.
Chimia (Aarau)
; 77(6): 376-383, 2023 Jun 28.
Article
em En
| MEDLINE
| ID: mdl-38047776
ABSTRACT
The fortieth anniversary of biocatalysis started at Ciba-Geigy and later at Novartis is a great time to pause and reflect on development of science and technology in this field. Enzyme-based synthesis became a highly valued enabling tool for pharmaceutical research and development over the last decades. In this perspective we aim to discuss how the scientific approaches and trends evolved over the time and present future challenges and opportunities.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Biocatálise
Idioma:
En
Revista:
Chimia (Aarau)
Ano de publicação:
2023
Tipo de documento:
Article